Compounds for flaviviridae treatment

Details for Australian Patent Application No. 2005322241 (hide)

Owner Novartis AG.

Inventors Weidmann, Beat

Agent Davies Collison Cave

Pub. Number AU-B-2005322241

PCT Pub. Number WO2006/071618

Priority 60/638,676 23.12.04 US

Filing date 20 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 18 February 2010

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/071618 Priority application(s): WO2006/071618

18 February 2010 Application Accepted

  Published as AU-B-2005322241

17 June 2010 Standard Patent Sealed

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322242-Compositions for HCV treatment

2005322238-Method for determining distances from a device to at least a first and a second layer in a formation